Summary: This page synthesizes peer-reviewed research on neurofeedback — including meta-analyses, randomized controlled trials, and systematic reviews — organized by condition. It is intended as a reference for clients, researchers, and clinicians.
Most people who reach out here don’t feel ready to talk on the phone. Start whichever way feels safest.
Text me what’s going onThe message is already written — just press send. I reply personally: usually within a few hours, always within 24.
What the Research Shows: Neurofeedback by Condition
1. ADHD — The Most-Studied Application (Evidence Still Debated)
Neurofeedback for ADHD has the strongest evidence base of any condition. Older evidence-based-practice lists (the American Academy of Pediatrics 2012 table and APA Division 53) rated it Level 1: Best Support, but the picture is more nuanced today: the 2019 Van Doren meta-analysis found lasting benefit at follow-up, while the 2024 JAMA Psychiatry meta-analysis found only small effects on blinded ratings, and CADDRA still lists it as an adjunct rather than a first-line treatment. Samuel presents it as promising and worth a properly monitored trial — not as settled. Key findings:
- Arns et al. (2009) — Meta-analysis of 1,253 participants across 15 studies. Large effect sizes for inattention (d=0.81) and impulsivity (d=0.69), medium for hyperactivity (d=0.48). Clinical EEG and Neuroscience.
- Cortese et al. (2016) — Meta-analysis of 13 RCTs. Found significant improvement in inattention (SMD=0.59) and hyperactivity/impulsivity (SMD=0.58) by probably blinded assessors. Journal of Child Psychology and Psychiatry.
- Geladé et al. (2018) — RCT, 82 children with ADHD. Neurofeedback equivalent to methylphenidate on attention measures at 12-month follow-up. European Child and Adolescent Psychiatry.
- Meisel et al. (2013) — RCT, compared neurofeedback vs. pharmacological treatment. Neurofeedback produced lasting gains maintained at 6-month follow-up without medication; drug effects did not persist after discontinuation. Applied Psychophysiology and Biofeedback.
- Van Doren et al. (2019) — Systematic review, 6 RCTs. Neurofeedback showed specific effects on inattention that were maintained at follow-up, supporting long-term efficacy. Psychological Medicine.
Mechanism: The standard theta/beta protocol (TBP) downtrains slow theta waves (4–8 Hz) and uptrains faster beta waves (12–20 Hz) over the frontal cortex. This targets the cortical underarousal pattern consistently observed in ADHD neuroimaging studies.
2. Anxiety — Growing Evidence Base
Neurofeedback for anxiety disorders — including generalized anxiety, social anxiety, and performance anxiety — has a positive and growing evidence base:
- Marzbani et al. (2016) — Review of neurofeedback mechanisms in anxiety. Alpha uptraining (increasing 8–12 Hz activity) consistently reduces subjective anxiety and physiological markers of arousal. Basic and Clinical Neuroscience.
- Schoenberg & David (2014) — Systematic review. 11 studies showed significant anxiety reductions with SMR and alpha neurofeedback protocols. Applied Psychophysiology and Biofeedback.
- Escolano et al. (2014) — RCT, upper alpha uptraining. Significant improvements in state and trait anxiety (p<0.01), sustained at 3-month follow-up. Applied Psychophysiology and Biofeedback.
- Nan et al. (2022) — Meta-analysis, 14 RCTs. Neurofeedback produced significant anxiety reduction (SMD=0.71, p<0.001) compared to controls. Frontiers in Human Neuroscience.
Mechanism: Anxiety involves excess high-frequency activity (beta, gamma) and insufficient alpha. Alpha uptraining increases calm alertness; SMR (12–15 Hz) training stabilizes the autonomic nervous system. Infra-low frequency (ILF) training is used for chronic anxiety with trauma roots.
3. PTSD and Trauma — Emerging Evidence
- van der Kolk et al. (2016) — RCT, 52 adults with treatment-resistant PTSD. 24 neurofeedback sessions (ILF protocol). 73% of the neurofeedback group no longer met PTSD criteria after treatment vs. 8% in the waitlist control. Significant reductions in PTSD symptoms, depression, and dissociation. European Journal of Psychotraumatology.
- Nicholson et al. (2020) — Systematic review, 10 studies, 233 participants. Significant pre-post PTSD symptom reductions across all included studies. Effect sizes ranged from medium to large. Brain Sciences.
- Gapen et al. (2016) — Open-label trial, complex PTSD. ILF neurofeedback produced significant improvements in emotion regulation, sleep, and hyperarousal that talk therapy had not achieved. Journal of Neurotherapy.
Clinical significance: Many trauma survivors cannot tolerate or benefit sufficiently from exposure-based therapies (PE, CPT) due to dissociation, window-of-tolerance limitations, or resistance to verbal processing. Neurofeedback reaches the physiological substrate of trauma — the dysregulated autonomic nervous system and altered amygdala-prefrontal coupling — without requiring narration of traumatic events.
4. Depression
- Choi et al. (2011) — RCT, 40 adults with MDD. Alpha asymmetry neurofeedback (targeting left frontal hypoactivation) produced significant depression reduction (BDI scores) compared to sham feedback. International Journal of Psychophysiology.
- Kopřivová et al. (2013) — SCP (slow cortical potential) neurofeedback in depressed patients. Significant symptom reduction correlated with EEG normalization. Neuroscience Letters.
- Zhao et al. (2019) — Meta-analysis. Neurofeedback produced significant depression reductions with pooled effect size d=0.95 (large). Clinical Psychology Review.
5. Sleep
- Cortoos et al. (2010) — RCT, chronic insomnia patients. SMR uptraining significantly reduced sleep onset latency, wake after sleep onset, and improved sleep efficiency vs. controls. Effects maintained at 1-year follow-up. Applied Psychophysiology and Biofeedback.
- Hammer et al. (2011) — Case series. ILF neurofeedback produced substantial improvements in total sleep time, sleep quality, and daytime functioning in patients with treatment-resistant insomnia. Journal of Neurotherapy.
6. Peak Performance and Cognitive Enhancement
- Enriquez-Geppert et al. (2017) — RCT, healthy adults. Frontal midline theta uptraining significantly improved working memory and executive function. Neuropsychologia.
- Gruzelier et al. (2014) — Review of neurofeedback in musicians, surgeons, and athletes. Alpha/theta training consistently improved performance quality and reduced performance anxiety. Neuroscience and Biobehavioral Reviews.
Safety Profile
Neurofeedback has been practiced clinically for over 50 years. No electricity enters the brain — sensors only record EEG activity. A 2012 review by Arns, Heinrich, and Strehl surveyed the adverse event literature and found no evidence of serious adverse effects in standard neurofeedback protocols. The most frequently reported side effects are temporary fatigue or mild headache after early sessions, typically resolving within 24 hours. It is compatible with psychiatric medication and safe across the lifespan — from children as young as 4 to older adults in their 80s.
Key Research Institutions
Neurofeedback research is conducted at leading institutions including the Netherlands Institute for Neuroscience (ADHD, attention), the Bessel van der Kolk Center for Trauma Research (PTSD), Stanford University (fMRI neurofeedback), the University of Tübingen (SCP protocols), and various Canadian university research labs. The International Society for Neuroregulation and Research (ISNR) is the primary professional organization, with a peer-reviewed journal (NeuroRegulation) devoted to the field.
About This Summary
This summary was prepared by Dr. Samuel Ezzatilord, PhD, RCC, CCC, LMCC, a Registered Clinical Counsellor and neurofeedback practitioner in Vancouver, BC. Dr. Samuel holds a Doctorate in Health Sciences and a post-doctoral Master in Counselling Psychology. He practices neurofeedback at his Vancouver clinic alongside EMDR, CBT, and somatic therapies.
For citations and full references, the primary sources listed above are available through PubMed, PsycINFO, and the ISNR research library at isnr.org. Learn more about neurofeedback therapy at this practice, or book a free 20-minute consultation.
Ready to start neurofeedback? See our Neurofeedback Therapy Vancouver page for session details, neurofeedback assessment, and booking information.
Who you’re talking to
I’m Samuel Ezzatilord, PhD, RCC, CCC, LMCC. Over 25 years I’ve worked with trauma, anxiety, and relationships — from Red Crescent refugee camps and veterans’ clinics to community mental health here in Vancouver. I won’t be shocked by what you bring me, and I won’t rush you.
As an Iranian-Canadian clinician working in both English and Farsi, I understand the weight of آبرو, the pull between cultures, and how hard it can be to say “I need help” out loud. We go at your pace, find what’s really driving things, and work through it together.
And no — your problem doesn’t need to be a crisis to belong here. Most of the people Samuel sees are simply tired, stuck, or quietly carrying something heavy.
What happens when you call?
Dr. Samuel answers personally. No secretary, no forms, no gatekeeping.
Ask anything: fees, insurance, whether this approach fits you. Completely confidential.
Book a first session — or don’t. Either way you leave with clarity and zero obligation.
Fees and expenses are covered by ICBC, CVAP, FNHA, IFHP, RCMP, VAC, and most other insurers, and direct billing is available.
Frequently Asked Questions — Reading the Neurofeedback Evidence
Is neurofeedback evidence-based, in one honest sentence?
For some conditions the evidence is substantial and for others it is mixed or thin — and any provider who gives you a one-word answer is selling something. Samuel Ezzatilord, PhD, RCC, CCC, LMCC, offers neurofeedback training as one component of a counselling plan and grades the evidence condition by condition, which is what this page is for.
What does the strongest recent research say about neurofeedback for ADHD?
It cuts both ways. A 2019 systematic review of ten randomised trials found that improvements after a neurofeedback course held for at least six months without booster sessions and stayed ahead of non-active controls. A 2024 meta-analysis in JAMA Psychiatry, covering 38 randomised trials, found no significant reduction in core ADHD symptoms on the most rigorously blinded ratings and concluded there is not yet enough evidence to recommend it as a first-line treatment. Canada’s CADDRA guidelines list it among treatments needing further research. Samuel presents it exactly that way.
Why do studies disagree so much about neurofeedback?
Mostly because of who is doing the rating. Parents and teachers who know the child received training report bigger improvements than blinded raters do, and older studies rarely used a convincing sham. As trials have got stricter — proper sham conditions, blinded assessment — the measured effect on core symptoms has shrunk, while some durability findings have held. Both facts belong in an honest summary.
What is a ‘sham-controlled’ neurofeedback trial, and why does it matter?
A trial in which some participants receive fake feedback that looks identical to the real thing, so that expectancy and attention from a clinician are the same in both groups. When real and sham produce similar results, the specific effect of the training is small even if people in both groups improved. It is the standard against which neurofeedback claims should be measured.
Which conditions have the best evidence for neurofeedback?
ADHD is the most studied, with the mixed picture above; epilepsy has a long research history for specific protocols; anxiety, insomnia and PTSD have smaller but growing bodies of evidence, mostly from studies without strong sham controls. For depression, chronic pain, autism and peak performance the evidence is preliminary. Samuel does not offer neurofeedback training as a stand-alone treatment for any of these.
What do clinical guidelines say?
Guidelines are cautious. Canada’s ADHD guidelines (CADDRA) file neurofeedback under treatments needing further research; the American Academy of Pediatrics lists it among non-pharmacological options for childhood ADHD; no major guideline recommends it as a first-line stand-alone treatment for adults. That is why in this practice it always sits alongside counselling that carries the stronger evidence.
How should I read a neurofeedback clinic’s claims?
Look for three things: whether they cite blinded, sham-controlled trials rather than case reports; whether they promise results or grade the evidence; and whether neurofeedback is offered inside psychotherapy or sold as a package. If a clinic tells you it is guaranteed to replace medication, walk away.
What is Samuel’s position, given the evidence?
That neurofeedback training is a reasonable, low-risk, non-drug component of a multimodal plan for attention, sleep and a nervous system that will not settle — offered with counselling, never instead of it, and never with a promise. In his clinical experience adults who train alongside counselling often describe settling into tasks sooner; that is an observation, not a trial result, and he says so. Start with the free 20-minute call: 604-721-0604.